Search

everythinglearnresearchcommunity

for

Search:↓

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Dupilumab may help regrow hair in people with severe alopecia.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Genetic discoveries are leading to new treatments for alopecia areata.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

The 2012 criteria are better for diagnosing atypical lupus cases.

Hair follicle-derived melanocyte transplant could effectively treat vitiligo by restoring skin color.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Understanding sex and gender differences can improve personalized dermatology care.